Produção Nacional
Revisado por pares
Capacity for the management of kidney failure in the International Society of Nephrology Latin America region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)
2024; Elsevier BV; Volume: 13; Issue: 1 Linguagem: Inglês
10.1016/j.kisu.2024.01.001
ISSN2157-1724
AutoresViviane Cálice-Silva, Javier A. Neyra, Alejandro Ferreiro Fuentes, Krissia Kamile Singer Wallbach Massai, Silvia Arruebo, Aminu K. Bello, Fergus Caskey, Sandrine Damster, Jo‐Ann Donner, Vivekanand Jha, David W. Johnson, Adeera Levin, Charu Malik, Masaomi Nangaku, Ikechi G. Okpechi, Marcello Tonelli, Feng Ye, Magdalena Madero, Carmen Tzanno‐Martins, Guillermo Álvarez, Atefeh Amouzegar, Denisse Arellano-Mendez, Gustavo Aroca, Roger Ayala Ferrari, Carlos Bonano, Edwin Castillo Velarde, Jonathan Samuel Chavez Iñiguez, Yeoungjee Cho, Rolando Claure‐Del Granado, Ricardo Correa–Rotter, Alfonso M. Cueto‐Manzano, Ana María Cusumano, Mogamat Razeen Davids, Sara N. Davison, Hassane M. Diongole, Smita Divyaveer, Udeme E. Ekrikpo, Isabelle Éthier, Ana Elizabeth Figueiredo, Winston Wing‐Shing Fung, Guillermo García-García, Anukul Ghimire, Martin Gomez, Maria Carlota Gonzalez Bedat, Ghenette Houston, Htay Htay, Kwaifa Salihu Ibrahim, Georgina Irish, Kailash Jindal, Dearbhla Kelly, Rowena Lalji, José A. Moura-Neto, Aisha M. Nalado, Brendon L. Neuen, Óscar Noboa, Irene L. Noronha, Timothy O. Olanrewaju, Mohamed A. Osman, Ana Cecilia Pastor Ludena, Анна Петрова, Andrea Pio-Abreu, Parnian Riaz, Jorge Rico-Fontalvo, Guillermo Rosa-Díez, Syed Saad, Aminu Muhammad Sakajiki, Angel Cristóbal Santacruz, Juan Santacruz, Emily See, Augusto César Soares dos Santos, Laura Solá, Stephen M. Sozio, Sophanny Tiv, Hérnan Trimarchi, Somkanya Tungsanga, Andrea K. Viecelli, Marina Wainstein, Emily K. Yeung, Deenaz Zaidi,
Tópico(s)Acute Kidney Injury Research
ResumoSuccessful management of chronic kidney disease (CKD) in Latin America (LA) continues to represent a challenge due to high disease burden and geographic disparities and difficulties in terms of capacity, accessibility, equity, and quality of kidney failure care. Although LA has experienced significant social and economic progress over the past decades, there are still important inequities in health care access. Through this third iteration of the International Society of Nephrology Global Kidney Health Atlas, the indicators regarding kidney failure care in LA are updated. Survey responses were received from 22 of 31 (71%) countries in LA representing 96.5% of its total population. Median CKD prevalence was 10.2% (interquartile range: 8.4%–12.3%), median CKD disability-adjusted life year was 753.4 days (interquartile range: 581.3–1072.5 days), and median CKD mortality was 5.5% (interquartile range: 3.2%–6.3%). Regarding dialysis modality, hemodialysis continued to be the most used therapy, whereas peritoneal dialysis reached a plateau and kidney transplantation increased steadily over the past 10 years. In 20 (91%) countries, >50% of people with kidney failure could access dialysis, and in only 2 (9%) countries, people who had access to dialysis could initiate dialysis with peritoneal dialysis. A mix of public and private systems collectively funded most aspects of kidney replacement therapy (dialysis and transplantation) with many people incurring up to 50% of out-of-pocket costs. Few LA countries had CKD/kidney replacement therapy registries, and almost no acute kidney injury registries were reported. There was large variability in the nature and extent of kidney failure care in LA mainly related to countries' funding structures and limited surveillance and management initiatives. Successful management of chronic kidney disease (CKD) in Latin America (LA) continues to represent a challenge due to high disease burden and geographic disparities and difficulties in terms of capacity, accessibility, equity, and quality of kidney failure care. Although LA has experienced significant social and economic progress over the past decades, there are still important inequities in health care access. Through this third iteration of the International Society of Nephrology Global Kidney Health Atlas, the indicators regarding kidney failure care in LA are updated. Survey responses were received from 22 of 31 (71%) countries in LA representing 96.5% of its total population. Median CKD prevalence was 10.2% (interquartile range: 8.4%–12.3%), median CKD disability-adjusted life year was 753.4 days (interquartile range: 581.3–1072.5 days), and median CKD mortality was 5.5% (interquartile range: 3.2%–6.3%). Regarding dialysis modality, hemodialysis continued to be the most used therapy, whereas peritoneal dialysis reached a plateau and kidney transplantation increased steadily over the past 10 years. In 20 (91%) countries, >50% of people with kidney failure could access dialysis, and in only 2 (9%) countries, people who had access to dialysis could initiate dialysis with peritoneal dialysis. A mix of public and private systems collectively funded most aspects of kidney replacement therapy (dialysis and transplantation) with many people incurring up to 50% of out-of-pocket costs. Few LA countries had CKD/kidney replacement therapy registries, and almost no acute kidney injury registries were reported. There was large variability in the nature and extent of kidney failure care in LA mainly related to countries' funding structures and limited surveillance and management initiatives. Update on variability in organization and structures of kidney care across world regionsKidney International SupplementsVol. 13Issue 1PreviewGlobally, the number of people suffering from kidney disease is approaching 1 billion.1 This estimate is almost twice the number of people living with diabetes mellitus2 in 2021, and more than 20 times the number of people living with the human immunodeficiency virus (HIV) in 2022.3 Kidney disease recently has been ranked among the top-10 leading causes of death worldwide by the World Health Organization (WHO).4 Progression of chronic kidney disease (CKD) to kidney failure is associated with poor outcomes, including loss of life years, catastrophic health expenditures, reduced quality of life, and excess mortality. Full-Text PDF Variations in kidney care management and access: regional assessments of the 2023 International Society of Nephrology Global Kidney Health Atlas (ISN-GKHA)Kidney International SupplementsVol. 13Issue 1PreviewWorldwide, substantial evidence shows the rising incidence and prevalence of chronic kidney disease (CKD) and kidney failure requiring dialysis or transplantation.1 Evidence also links CKD and kidney failure with excess morbidity and mortality2 and immense economic challenges3 for families and countries. Nearly a billion people are estimated to be living with kidney disease worldwide.4 CKD, which ranks 12th among global causes of death, accounted for 1.43 million deaths in 2019, a 137% increase from 1990. Full-Text PDF
Referência(s)